Código QR (código de barras bidimensional)

Immunogenicity and safety of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine: a systematic review

Abstract Background Heterologous prime-boost with ChAdOx1 nCoV-19 vector vaccine (ChAd) and a messenger RNA vaccine (BNT or mRNA-1273) has been widely facilitating mass coronavirus disease 2019 (COVID-19) immunisation. This review aimed to synthesize immunogenicity and reactogenicity of heterologous...

ver descrição completa

Na minha lista:
Principais autores: Jingjing Lv, Hui Wu, Junjie Xu, Jiaye Liu
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2022-05-01
coleção:Infectious Diseases of Poverty
Assuntos:
Homologous vaccination
Heterologous vaccination
COVID-19
Immunogenicity
Safety
Acesso em linha:https://doi.org/10.1186/s40249-022-00977-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados